peatedly until tobacco use has stopped).
We recommend statin therapy in patients with symptomatic PAD.
We recommend optimizing diabetes control (hemoglobin A1c goal of <7.0%) in patients with
IC if this goal can be achieved without hypoglycemia.
We recommend the use of indicated b-blockers (eg, for hypertension, cardiac indications) in
patients with IC. There is no evidence supporting concerns about worsening claudication
symptoms.
In patients with IC due